Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosinase, collagenase, and elastase represent a triad of enzymes that are central to the structural integrity and pigmentation of human skin. Tyrosinase (EC 1.14.18.1) is a copper-containing oxidase that acts as the rate-limiting enzyme in the melanogenesis pathway, responsible for the production of melanin; its overactivity is directly linked to hyperpigmentation disorders such as melasma and solar lentigines [Pillaiyar et al., J Enzyme Inhib Med Chem, 2017]. Collagenase (primarily Matrix Metalloproteinase-1, MMP-1) and elastase (including Neutrophil Elastase and MMP-12) are proteolytic enzymes that catalyze the degradation of collagen and elastin fibers within the extracellular matrix [Thring et al., BMC Complement Altern Med, 2009]. The balance between the synthesis and degradation of these fibers is crucial for skin elasticity and strength, and an increase in these enzymes—often triggered by ultraviolet radiation—leads to the clinical manifestations of photoaging, such as wrinkles and sagging [Pittayapruek et al., Int J Mol Sci, 2016]. Pharmacological and cosmeceutical strategies frequently involve the use of inhibitors like kojic acid for tyrosinase or retinoids to modulate protease expression, aiming to preserve the dermal matrix and regulate skin tone [Mukherjee et al., Clin Interv Aging, 2006]. Because this entry groups three distinct proteins with different catalytic mechanisms and genetic origins, it is typically treated as a multi-target panel rather than a single therapeutic entity.
Inhibition of tyrosinase prevents melanin synthesis; inhibition of collagenase and elastase prevents the breakdown of structural proteins in the extracellular matrix.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosinase, collagenase, and elastase.